Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2008
10/30/2008WO2008131441A1 Methods and compositions involving ltas
10/30/2008WO2008131374A1 Use of low temperature and/or low ph in cell culture
10/30/2008WO2008131094A1 Method for controlling glucose uptake and insulin sensitivity
10/30/2008WO2008131014A1 Lipopeptides and lipopeptide synthetases
10/30/2008WO2008130248A1 Improvements in and relating to oil production plants
10/30/2008WO2008130053A1 Fused protein comprising protein g with avidin
10/30/2008WO2008130036A1 Method for production of antimutagenic substance using lactic acid bacterium
10/30/2008WO2008129971A1 Improved persistently infective sendai virus vector
10/30/2008WO2008129422A1 Demannosylated recombinant factor viii for the treatment of patients with haemophilia a
10/30/2008WO2008128973A2 Solutions of mannoproteins and their use
10/30/2008WO2008128972A1 Peptide mixture as wine stabiliser
10/30/2008WO2008128701A2 Yeast expression systems
10/30/2008WO2008128456A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof
10/30/2008WO2008128345A1 ENGINEERED VERSIONS OF CGTB (β-1,3- GALACTOSYLTRANSFERASE) ENZYMES, WITH ENHANCED ENZYMATIC PROPERTIES
10/30/2008WO2008110653B1 Antibody producing microorganism, elements required to obtain same, resulting antibodies, therapeutic compositions and use of thereof
10/30/2008WO2008109533A3 Human antibodies that bind multiple irta family proteins, and uses thereof
10/30/2008WO2008097817A3 Multivariable antigens complexed with targeting humanized monoclonal antibody
10/30/2008WO2008088895A3 Synthetic mini/micro-dystrophin genes to restore nnos to the sarcolemma
10/30/2008WO2008088884A3 Enhanced cell-free synthesis of active proteins containing disulfide bonds
10/30/2008WO2008079172A3 Compositions comprising hmw-maa and fragments thereof, and methods of use thereof
10/30/2008WO2008078177A3 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence
10/30/2008WO2008073312A3 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof
10/30/2008WO2008070593A3 Variant target binding agents and uses thereof
10/30/2008WO2008054724A3 Monoclonal antibodies against osteopontin
10/30/2008WO2007127200A3 Antibiotic compounds
10/30/2008WO2007109307A3 Antibodies directed to angiopoietin-like protein 4 and uses thereof
10/30/2008WO2005111204A3 Porcine forssman synthetase cdna and polypeptide
10/30/2008WO2004112717A3 Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof
10/30/2008US20080271207 Lipase Polypeptide
10/30/2008US20080271205 Cytochrome p450 for use as tool to increase stevoside concentration in plant cells; identifying and manufature of sugar substitutes; artificial sweetners
10/30/2008US20080271167 for treatment of viral infection and nervous systtem disorders
10/30/2008US20080269537 Crustacean metallothionein polypeptide; bioremediation; pollution control
10/30/2008US20080269465 Tumor necrosis factor specific immunoglobulin for use in prevention and treatment of rheumatoid arthritis, ulcerative colitis, multiple sclerosis and crohn's disease
10/30/2008US20080269158 E2epf Ubiquitin Carrier Protein-Von Hippel-Lindau Interaction and Uses Thereof
10/30/2008US20080269147 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response; autoimmune disease; tumor-associated gene
10/30/2008US20080269139 FGF-5 Supported and Binding Peptides
10/30/2008US20080269132 Use of low temperature and/or low ph in cell culture
10/30/2008US20080269113 P53 binding t cell receptor molecules
10/30/2008US20080268536 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
10/30/2008US20080268526 Methods for producing secreted polypeptides
10/30/2008US20080268523 Using vector transformation to generate transgenic organism which can express heterologous protein in high and low temperatures
10/30/2008US20080268503 Method for Achieving High-Level Expression of Recombinant Human Interleukin-2 Upon Destabilization of the Rna Secondary Structure
10/30/2008US20080268502 Multiple Promoters and the Use Thereof For Gene Expression
10/30/2008US20080268501 Methods and materials relating to gene expression
10/30/2008US20080268500 Capable synthesising mono-, bi- and/or tri-cyclic sesquiterpenes having a C2-C7 or a C3-C7 bond, via farnesyl-pyrophosphate precursor; for catalyzing cyclisation to the santalene and bergamotene carbon skeletons
10/30/2008US20080268499 Nucleotide sequences coding hormone recptors for use in identifying modulaors of insect propagation; biological pest control; insecticides
10/30/2008US20080268498 Heat resistant polymerase for propagation of preferential nucleotide sequences
10/30/2008US20080268470 Methods of selecting cell clones
10/30/2008US20080267985 Major allergen Phl p 1 comprising reduced immunoglobulin reactivity for use in treating grass pollen allergies; immunotherapy
10/30/2008US20080267979 Heparan sulfate proteoglycan specific immunoglobulin for use in treatment and prevention of liver cancers
10/30/2008US20080267974 Tumor necrosis factor specific immunoglobulin for use in diagnosis and treatment of autoimmune diseases
10/30/2008US20080267958 Lymphatic endothelial glycoprotein for use as tool in identifying modulators for prevention and treatment of inflammation and cell proliferative disorders
10/30/2008US20080267953 Anti-perp recombinant antibody
10/30/2008US20080267944 Expression vector comprising nucleotide sequences coding serine potease like protein for use in depleting fibrinogen from blood and diagnosing dysprothrombinemias
10/30/2008US20080267910 Nucleotide sequences coding interleukin-21/22 for use in identifying modulators for prevention and treatment of viral infection and cell proliferative disorders
10/30/2008US20080267871 Cardioinhibitory/ Antihypertensive Novel Endogenous Physiologically Active Peptide
10/30/2008CA2689481A1 Engineered versions of cgtb (.beta.-1,3-galactosyltransferase) enzymes, with enhanced enzymatic properties
10/30/2008CA2685185A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof
10/30/2008CA2684834A1 Demannosylated recombinant factor viii for the treatment of patients with haemophilia a
10/30/2008CA2684727A1 Use of low temperature and/or low ph in cell culture
10/30/2008CA2684707A1 Mo-1, a gene associated with morbid obesity
10/30/2008CA2684650A1 Expression system
10/30/2008CA2684626A1 Penta-specific antibodies binding il-8, gro-alpha, gro-beta, gro-gamma and ena-78
10/30/2008CA2684254A1 Method for controlling glucose uptake and insulin sensitivity
10/30/2008CA2680487A1 Peptide mixture as wine stabiliser
10/30/2008CA2680396A1 Mannoprotein liquid formulations
10/29/2008EP1985711A1 Method for efficient purification of bionanocapsule
10/29/2008EP1985705A2 Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections
10/29/2008EP1985703A2 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
10/29/2008EP1985701A2 Genes differentially expressed in breast cancer
10/29/2008EP1985698A1 Peptidases from basidiomycetes
10/29/2008EP1985628A1 Bis-met histones
10/29/2008EP1985625A2 Synthetic peptide constructs for the diagnosis and treatment of periodontitus associated with porphyromonas gingivalis
10/29/2008EP1985306A2 TRX1 antibody and uses therefor
10/29/2008EP1984523A2 Mutant jak3 kinase in human leukemia
10/29/2008EP1984517A2 Methods for modulating mannose content of recombinant proteins
10/29/2008EP1984508A2 Nucleic acid constructs and methods for producing altered seed oil compositions
10/29/2008EP1984399A2 Transducible delivery of sirna by dsrna binding domain fusions to ptd/cpps
10/29/2008EP1984023A2 Soluble fragments of the sars-cov spike glycoprotein
10/29/2008EP1984013A2 Modifications of cst-ii for increased protein expression
10/29/2008EP1669445B1 Novel vector and utilization of the same
10/29/2008EP1619208B1 Chaperonine-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure of target protein, sustained-release preparation and method of producing antibody against target protein
10/29/2008EP1297145B1 Streptococcus pyogenes antigen
10/29/2008EP1222208B1 Polypeptide derivatives of parathyroid hormone (pth)
10/29/2008EP1116791B1 Novel tumor antigen protein sart-3 and tumor antigen peptide thereof
10/29/2008EP1054693B1 Inhibitors of complement activation
10/29/2008EP1017785B1 Rna export element
10/29/2008EP0979292B1 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
10/29/2008EP0961831B1 Human endokine alpha
10/29/2008EP0919621B1 Human tak1 and dna encoding the same
10/29/2008EP0846128B1 Antimicrobial cationic peptides and methods of screening for the same
10/29/2008EP0752872B1 Nadh oxidase as a target in diagnosis and therapy
10/29/2008CN101296938A Production method of colistin rough material powder
10/29/2008CN101294188A Lactoferrin antimicrobial peptide, preparing method and uses thereof
10/29/2008CN101294187A Method for sustained-releasing polypeptide with biological activity and application thereof
10/29/2008CN101294186A Method for preparing donkey-hide gelatin oligopeptide
10/29/2008CN101294185A Method for preparing fish scale collagen peptide with multi-bactery mix fermentation
10/29/2008CN101294184A Method for preparing hypodermotin C by using pichia stipitis
10/29/2008CN101294183A Method for preparing protein peptide with immobilization proteolytic enzyme protolysate
10/29/2008CN101294164A Expression of recombinant human metaphase factor (rh-Midkine), preparation and application of monoclone antibody